Beigene Stock Odds of Future Stock Price Finishing Under 167.39

BGNE Stock  USD 154.70  7.88  4.85%   
BeiGene's implied volatility is one of the determining factors in the pricing options written on BeiGene. Implied volatility approximates the future value of BeiGene based on the option's current value. Options with high implied volatility have higher premiums and can be used to hedge the downside of investing in BeiGene over a specific time period. For example, 2024-06-21 CALL at $155.0 is a CALL option contract on BeiGene's common stock with a strick price of 155.0 expiring on 2024-06-21. The contract was last traded on 2024-06-12 at 12:34:04 for $13.74 and, as of today, has 3 days remaining before the expiration. The option is currently trading at a bid price of $3.6, and an ask price of $8.0. The implied volatility as of the 18th of June 2024 is 54.17. View All BeiGene options

Closest to current price BeiGene long CALL Option Payoff at Expiration

BeiGene's future price is the expected price of BeiGene instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of BeiGene performance during a given time horizon utilizing its historical volatility. Check out BeiGene Backtesting, BeiGene Valuation, BeiGene Correlation, BeiGene Hype Analysis, BeiGene Volatility, BeiGene History as well as BeiGene Performance.
For information on how to trade BeiGene Stock refer to our How to Trade BeiGene Stock guide.
  
The current year's Price Earnings To Growth Ratio is expected to grow to 0.40, whereas Price To Sales Ratio is forecasted to decline to 7.27. Please specify BeiGene's target price for which you would like BeiGene odds to be computed.

BeiGene Target Price Odds to finish below 167.39

The tendency of BeiGene Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to stay under $ 167.39  after 90 days
 154.70 90 days 167.39 
about 82.32
Based on a normal probability distribution, the odds of BeiGene to stay under $ 167.39  after 90 days from now is about 82.32 (This BeiGene probability density function shows the probability of BeiGene Stock to fall within a particular range of prices over 90 days) . Probability of BeiGene price to stay between its current price of $ 154.70  and $ 167.39  at the end of the 90-day period is about 42.53 .
Given the investment horizon of 90 days the stock has the beta coefficient of 1.73 suggesting as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, BeiGene will likely underperform. Additionally BeiGene has an alpha of 0.1161, implying that it can generate a 0.12 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
   BeiGene Price Density   
       Price  

Predictive Modules for BeiGene

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as BeiGene. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of BeiGene's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
156.60159.57162.54
Details
Intrinsic
Valuation
LowRealHigh
143.44190.32193.29
Details
Naive
Forecast
LowNextHigh
172.83175.80178.78
Details
21 Analysts
Consensus
LowTargetHigh
266.20292.53324.71
Details

BeiGene Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. BeiGene is not an exception. The market had few large corrections towards the BeiGene's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold BeiGene, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of BeiGene within the framework of very fundamental risk indicators.
α
Alpha over NYSE Composite
0.12
β
Beta against NYSE Composite1.73
σ
Overall volatility
10.68
Ir
Information ratio 0.04

BeiGene Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of BeiGene for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for BeiGene can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
BeiGene generated a negative expected return over the last 90 days
The company reported the previous year's revenue of 2.46 B. Net Loss for the year was (881.71 M) with loss before overhead, payroll, taxes, and interest of (511.06 M).
BeiGene currently holds about 5.7 B in cash with (1.16 B) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 55.17.
BeiGene has a poor financial position based on the latest SEC disclosures
Roughly 20.0% of the company shares are held by company insiders
Latest headline from businesswire.com: BeiGene to Present New Data from SEQUOIA Study Evaluating BRUKINSA plus Venetoclax in High-Risk First-Line CLLSLL at EHA2024

BeiGene Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of BeiGene Stock often depends not only on the future outlook of the current and potential BeiGene's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. BeiGene's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding104.4 M
Cash And Short Term Investments3.2 B

BeiGene Technical Analysis

BeiGene's future price can be derived by breaking down and analyzing its technical indicators over time. BeiGene Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of BeiGene. In general, you should focus on analyzing BeiGene Stock price patterns and their correlations with different microeconomic environments and drivers.

BeiGene Predictive Forecast Models

BeiGene's time-series forecasting models is one of many BeiGene's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary BeiGene's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about BeiGene

Checking the ongoing alerts about BeiGene for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for BeiGene help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
BeiGene generated a negative expected return over the last 90 days
The company reported the previous year's revenue of 2.46 B. Net Loss for the year was (881.71 M) with loss before overhead, payroll, taxes, and interest of (511.06 M).
BeiGene currently holds about 5.7 B in cash with (1.16 B) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 55.17.
BeiGene has a poor financial position based on the latest SEC disclosures
Roughly 20.0% of the company shares are held by company insiders
Latest headline from businesswire.com: BeiGene to Present New Data from SEQUOIA Study Evaluating BRUKINSA plus Venetoclax in High-Risk First-Line CLLSLL at EHA2024

Additional Information and Resources on Investing in BeiGene Stock

When determining whether BeiGene is a strong investment it is important to analyze BeiGene's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact BeiGene's future performance. For an informed investment choice regarding BeiGene Stock, refer to the following important reports:
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of BeiGene. If investors know BeiGene will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about BeiGene listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(7.54)
Revenue Per Share
26.458
Quarterly Revenue Growth
0.679
Return On Assets
(0.12)
Return On Equity
(0.21)
The market value of BeiGene is measured differently than its book value, which is the value of BeiGene that is recorded on the company's balance sheet. Investors also form their own opinion of BeiGene's value that differs from its market value or its book value, called intrinsic value, which is BeiGene's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because BeiGene's market value can be influenced by many factors that don't directly affect BeiGene's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between BeiGene's value and its price as these two are different measures arrived at by different means. Investors typically determine if BeiGene is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BeiGene's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.